Charles J Ryan, MD is the Director of the Hematology, Oncology and Transplantation Division in the Dept. of Medicine at the University of Minnesota. He also holds the B.J. Kennedy Chair in Clinical Medical Oncology. He attended the University of Wisconsin Medical School and he trained there, serving as Chief Resident, and at Memorial Sloan-Kettering. He was then on the faculty of UCSF where he served as Program Leader for Genitourinary Medical Oncology and was the Thomas Perkins Distinguished Professor in Cancer Research. Dr. Ryan is internationally recognized for his work focusing on the development of new treatments for advanced prostate cancer, as well as supportive care for men with prostate cancer. He has published over 175 articles and chapters in leading medical journals and has authored “The Virility Paradox: The Vast Influence of Testosterone on Our Bodies, Minds, and the World We Live In” released in February of 2018. Dr. Ryan is the Leader of the Advanced Prostate Cancer Cadre in the Alliance for Clinical Trials in Oncology, a national Clinical Trials group.
PARP Inhibition in Prostate Cancer
with Dr. Charles Ryan, M.D., Director of the Hematology, Oncology, Transplant Division in the Dept. of Medicine at the University of Minnesota